Literature DB >> 9287452

Delivery of vaccines to adults: correlations with physician knowledge and patient variables.

C O Hershey1, J Karuza.   

Abstract

Our objective was to explore reasons why vaccines are not provided to adult patients receiving primary health care. The study setting was a primary health care clinic in a urban hospital staffed primarily by residents and teaching faculty. The patients were identified as all continuity care patients with a scheduled visit to the clinic during the 4-week study period in April 1995. The providers were all primary care providers for the patients during the study period. The providers were given two surveys before the study: one to assess their knowledge of published preventive health care guidelines and one to assess their perspective of the guidelines. During the study period, the charts of the patients were reviewed for the services they had received. An assessment was placed in each patient's chart for the provider's completion during the visit. The assessment enabled the provider to explain why services had not been provided. The results showed that influenza, pneumococcal, and diphtheria-tetanus vaccines were provided at varying rates. Each vaccine had a different profile as to noncompliance with guidelines. Lack of provider knowledge of the guideline was most apparent with pneumococcal vaccine. Providers' ambivalence regarding the scientific basis and/or clinical importance was most apparent with influenza vaccine. Patient refusal was a prominent cause with influenza vaccine in the elderly. Patient appointment behavior (opportunity for care and compliance) also seemed to play an important role. We conclude that explanations for nondelivery of vaccines to adults seem to be multiple. Lack of physician knowledge and physician perception of the guidelines provide some explanations. Patient-related factors including refusal, decreased opportunity for care, and noncompliance also play important roles in why vaccinations are not provided. Improvement in the rates at which immunizations to adults are provided will require interventions in multiple areas.

Entities:  

Mesh:

Year:  1997        PMID: 9287452     DOI: 10.1177/106286069701200302

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  6 in total

1.  The Influence of Patient Race and Socioeconomic Status and Resident Physician Gender and Specialty on Preventive Screening.

Authors:  Arshiya A Baig; Michele Heisler
Journal:  Semin Med Pract       Date:  2008-01-01

2.  Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children.

Authors:  Daniel A Salmon; William K Y Pan; Saad B Omer; Ann Marie Navar; Walter Orenstein; Edgar K Marcuse; James Taylor; M Patricia deHart; Shannon Stokley; Terrell Carter; Neal A Halsey
Journal:  Hum Vaccin       Date:  2008-02-19

3.  Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement.

Authors:  Sharmeel K Wasan; Audrey H Calderwood; Millie D Long; Michael D Kappelman; Robert S Sandler; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

4.  The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.

Authors:  Birthe A Lehmann; Renske Eilers; Liesbeth Mollema; José Ferreira; Hester E de Melker
Journal:  BMC Geriatr       Date:  2017-06-07       Impact factor: 3.921

5.  Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians.

Authors:  Michelle McNamara; Philip O Buck; Songkai Yan; Leonard R Friedland; Kristin Lerch; Alysa Murphy; Cosmina Hogea
Journal:  Hum Vaccin Immunother       Date:  2019-03-20       Impact factor: 3.452

6.  Implementing cognitive behavioral therapy in the real world: a case study of two mental health centers.

Authors:  Teresa L Kramer; Barbara J Burns
Journal:  Implement Sci       Date:  2008-02-29       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.